Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GH Research PLC (GHRS : NSDQ)
 
 • Company Description   
GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is based in DUBLIN.

Number of Employees: 14

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.15 Daily Weekly Monthly
20 Day Moving Average: 102,073 shares
Shares Outstanding: 50.52 (millions)
Market Capitalization: $512.79 (millions)
Beta:
52 Week High: $30.43
52 Week Low: $9.34
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -46.80% -41.71%
12 Week -43.80% -39.02%
Year To Date -56.49% -48.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
28 BAGGOT STREET
-
LOWER DUBLIN,L2 2D02 NX43
IRL
ph: 353-1437-8443
fax: -
investors@ghres.com http://www.ghres.com
 
 • General Corporate Information   
Officers
Theis Terwey - Chief Executive Officer
Florian Schonharting - Chairman
Michael Forer - Vice Chairman
Julie Ryan - Vice President; Finance
Dermot Hanley - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: G3855L106
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/27/22
Share - Related Items
Shares Outstanding: 50.52
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $512.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.78 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.85
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -125.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -4.31
09/30/21 - -3.74
ROA
03/31/22 - -
12/31/21 - -4.26
09/30/21 - -3.69
Current Ratio
03/31/22 - -
12/31/21 - 101.80
09/30/21 - 140.46
Quick Ratio
03/31/22 - -
12/31/21 - 101.80
09/30/21 - 140.46
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 5.49
09/30/21 - 5.61
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©